全ゲノム合成の世界市場

全ゲノム合成の世界市場は2030年までに208億米ドルに達する見込み

2024年に54億米ドルと推定される全ゲノム合成の世界市場は、2024年から2030年にかけてCAGR 25.3%で成長し、2030年には208億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるソフトウェア＆サービス・コンポーネントは、CAGR 27.7％を記録し、分析期間終了時には150億米ドルに達すると予想されます。消耗品セグメントは、分析期間中にCAGR 19.7%の成長が見込まれます。

米国市場は15億米ドルと推定、中国はCAGR 33.8％で成長予測

米国の全ゲノム合成市場は、2024年に15億米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024年から2030年にかけて33.8％のCAGRで推移し、2030年には52億米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ20.0%と22.8%と予測されています。欧州では、ドイツがCAGR 21.3%で成長すると予測されています。

世界の全ゲノム合成市場- 主要動向と促進要因のまとめ

全ゲノム合成は合成生物学の最前線をどのように再定義しているか？

全ゲノム合成は、既存のDNAを改変するのではなく、ゲノム全体をゼロから設計・構築することを可能にし、合成生物学において最も革新的な機能の一つとして浮上しています。バイオ燃料生産から耐病性、環境浄化に至るまで、特定の機能を発揮するカスタムデザインの生物を組み立てることができるようになったのです。この技術では、実験室で長いDNA鎖を合成し、宿主細胞に挿入できる機能的な染色体に組み立てる。一般的にゲノムの一部を編集する従来の遺伝子組み換えとは異なり、全ゲノム合成では遺伝子構造を完全にカスタマイズすることができるため、生物学的機能をこれまでになく制御することができます。これにより、産業、製薬、農業の用途に合わせた合成細胞を作り出す可能性が広がります。研究グループはすでに、最小限の生命体を研究し、遺伝子の本質性を理解し、細胞生命の境界を探求するために、細菌や酵母のゲノムを合成しています。これらの合成系はまた、新薬の試験、希少生体分子の生産、複雑な疾患のモデル化のためのプラットフォームとしても機能しています。DNA合成のコストが下がり続け、アセンブリー技術がより効率的になるにつれ、全ゲノム合成はライフサイエンスにおける革新の礎となり、これまで理論にとどまっていた新たな能力を解き放つことになると思われます。

技術進歩はゲノム合成の効率と精度をどのように加速しているのか？

急速な技術革新が全ゲノム合成の能力を押し上げ、プロセスをより速く、より正確に、そしてますますスケーラブルにしています。酵素合成やマイクロアレイベースのオリゴヌクレオチド生産などのハイスループットDNA合成技術の進歩により、研究者はエラー率を減らし、ターンアラウンドタイムを短縮して長いDNA配列を生成できるようになっています。ギブソンアセンブリーや形質転換関連組換えなどの自動組換え法は、より小さなDNA断片をより大きなゲノム構築物につなぎ合わせる効率を向上させています。これらの技術は、コドンの使用法を最適化し、折りたたみパターンを予測し、遺伝的安定性を確保するバイオインフォマティクス・ツールによって補完され、より機能的で信頼性の高い合成ゲノムの作成を可能にしています。機械学習と人工知能の統合は、遺伝子相互作用や代謝経路の挙動を予測することで設計段階をさらに洗練させ、遺伝子工学にありがちな試行錯誤を減らしています。品質管理も劇的に改善され、宿主生物に導入する前に、合成されたゲノムの正確性と完全性を検証するために次世代シーケンサーが日常的に使用されています。さらに、ベンチトップ合成プラットフォームと自動化ロボットシステムにより、研究室のスループットが向上し、アカデミックラボと産業ラボの両方が、より少ないリソースで大規模なゲノムプロジェクトを探求できるようになっています。このような進歩は、ゲノム合成へのアクセスをより幅広い研究者に広げるだけでなく、エネルギー、農業、健康などの分野で実用化される合成生物の商業的実現可能性を加速させています。

全ゲノム合成の需要を各業界で牽引している主な用途とは？

全ゲノム合成の実用的なアプリケーションは、様々な分野で急速に拡大しており、それぞれが合成ゲノムを活用して複雑な課題を解決し、新しい機能を導入しています。製薬業界では、カスタムゲノムを用いて、微生物をマイクロファクトリーとして機能させることで、希少な天然化合物、バイオシミラー、次世代抗生物質を生産しています。農業分野では、害虫抵抗性、干ばつ耐性、高収量の作物系統を開発するために合成ゲノムの研究が進められており、気候変動と世界人口の増加に直面する食糧安全保障への解決策を提供しています。バイオエネルギーの分野では、バイオマスを再生可能な燃料や化学物質に効率よく変換し、化石資源への依存を減らすために、合成微生物の調整が行われています。環境分野への応用としては、汚染物質の分解、廃棄物のリサイクル、二酸化炭素の隔離など、持続可能性の目標達成に貢献する生物の開発があります。さらに、合成ゲノムはワクチン開発においても重要な役割を果たしており、ウイルスベクターやアジュバントを正確に制御することで、有効性と安全性を高めています。学術機関や研究所もまた、合成ゲノムを利用して最小限の細胞を作り出し、生命や生物学的自己組織化の基本的要件について洞察を深めています。宇宙開発業界でも、地球外環境における生命維持システムや資源生成に利用できる可能性のある合成生物学を研究しています。ゲノム合成の広範な有用性と変革の可能性により、ゲノム合成は、科学的探究と現実の問題解決の両方において、分野を超えた中心的なツールとなっています。

ゲノム合成の世界的拡大に拍車をかけている市場勢力と戦略的動向とは？

全ゲノム合成の世界市場は、科学的野心、産業界の需要、そして戦略的投資が一体となって、遺伝子工学の規模と範囲を変革しつつあります。DNA合成のコスト低下は、アセンブリー技術や検証技術の進歩とともに、参入障壁を下げ、より多くの組織が合成ゲノム・プロジェクトに携わることを可能にしています。バイオテクノロジーの革新を目的とした政府の資金援助プログラムは、合成生物学の限界を押し広げようとする学術的・産業的取り組みを支援しており、ベンチャーキャピタルやバイオテクノロジー企業からの民間投資は商業化を加速させています。規制の枠組みも合成生物学に対応できるよう徐々に進化しており、より明確なガイドラインを提供し、透明性と安全性評価を通じて社会からの信頼を醸成しています。アカデミア、新興企業、既存のライフサイエンス企業間の協力関係の強化は、ゲノム合成能力が洗練され、多様な使用事例に応用される強固なイノベーション・エコシステムを育んでいます。バイオファウンドリーや専用の合成ラボの出現は、ハイスループットでコスト効率の高いゲノム工学を世界規模でサポートする集中ハブを形成しています。知的所有権戦略もまた、商業的価値のある新規な生物、方法、配列の特許を求める組織によって、市場力学を形成しています。同時に、人工生命の創造をめぐる倫理的な議論が、研究課題や社会的導入に影響を与える重要な対話を促しています。これらの力が収束することで、次世代バイオテクノロジー・ソリューションの変革要因として全ゲノム合成が立ちはだかる、ダイナミックで将来を見据えた市場が構築されつつあります。

セグメント

コンポーネント（ソフトウェア＆サービスコンポーネント、消耗品コンポーネント、機器コンポーネント）、アプリケーション（個別化医療アプリケーション、農業バイオテクノロジーアプリケーション、合成生物学アプリケーション、産業アプリケーション、その他アプリケーション）、エンドユーザー（製薬＆バイオテクノロジー企業エンドユーザー、診断研究所エンドユーザー、学術＆研究機関エンドユーザー、受託研究機関エンドユーザー）

調査対象企業の例

• Ansa Biotechnologies
• ATUM
• Azenta（GENEWIZ）
• Bio Basic Inc.
• Bioneer Pacific Co. Ltd.
• Blue Heron Biotech（OriGene）
• Brooks Automation
• Elegen Corporation
• Eurofins Genomics
• Genewiz（Azenta）
• GenScript Biotech Corporation
• Icon Genetics
• Integrated DNA Technologies
• J. Craig Venter Institute
• Merck KGaA
• ProteoGenix Inc.
• Synbio Technologies
• Synbio Technologies
• Thermo Fisher Scientific
• Twist Bioscience

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Whole Genome Synthesis Market to Reach US$20.8 Billion by 2030

The global market for Whole Genome Synthesis estimated at US$5.4 Billion in the year 2024, is expected to reach US$20.8 Billion by 2030, growing at a CAGR of 25.3% over the analysis period 2024-2030. Software & Service Component, one of the segments analyzed in the report, is expected to record a 27.7% CAGR and reach US$15.0 Billion by the end of the analysis period. Growth in the Consumables Component segment is estimated at 19.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.5 Billion While China is Forecast to Grow at 33.8% CAGR

The Whole Genome Synthesis market in the U.S. is estimated at US$1.5 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$5.2 Billion by the year 2030 trailing a CAGR of 33.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 20.0% and 22.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 21.3% CAGR.

Global Whole Genome Synthesis Market - Key Trends & Drivers Summarized

How Is Whole Genome Synthesis Redefining the Frontiers of Synthetic Biology?

Whole genome synthesis is emerging as one of the most transformative capabilities in synthetic biology, enabling scientists to design and construct entire genomes from scratch rather than modifying existing DNA. This advancement marks a significant leap forward in biological engineering, as researchers now have the ability to assemble custom-designed organisms that perform specific functions, ranging from biofuel production to disease resistance and environmental cleanup. The technique involves synthesizing long strands of DNA in a laboratory setting and assembling them into functional chromosomes that can be inserted into host cells. Unlike traditional genetic modification, which typically involves editing small segments of a genome, whole genome synthesis allows for the complete customization of genetic architecture, offering unprecedented control over biological functions. This opens up possibilities for creating synthetic cells tailored for industrial, pharmaceutical, and agricultural applications. Research groups are already synthesizing bacterial and yeast genomes to study minimal life forms, understand gene essentiality, and explore the boundaries of cellular life. These synthetic systems also serve as platforms for testing new drugs, producing rare biomolecules, and modeling complex diseases. As costs of DNA synthesis continue to decline and assembly techniques become more efficient, whole genome synthesis is positioned to become a cornerstone of innovation in life sciences, unlocking new capabilities that were previously confined to theory.

How Are Technological Advances Accelerating the Efficiency and Accuracy of Genome Synthesis?

Rapid technological innovations are propelling the capabilities of whole genome synthesis, making the process faster, more accurate, and increasingly scalable. Advances in high-throughput DNA synthesis techniques, such as enzymatic synthesis and microarray-based oligonucleotide production, are allowing researchers to generate long DNA sequences with reduced error rates and shorter turnaround times. Automated assembly methods, including Gibson assembly and transformation-associated recombination, are improving the efficiency of stitching together smaller DNA fragments into larger genomic constructs. These technologies are complemented by bioinformatics tools that optimize codon usage, predict folding patterns, and ensure genetic stability, enabling the creation of more functional and reliable synthetic genomes. The integration of machine learning and artificial intelligence is further refining the design phase by predicting gene interactions and metabolic pathway behavior, which reduces the trial-and-error typically associated with genetic engineering. Quality control has also seen dramatic improvements, with next-generation sequencing being routinely used to verify the accuracy and integrity of synthesized genomes before they are introduced into host organisms. Moreover, benchtop synthesis platforms and automated robotic systems are increasing laboratory throughput, enabling both academic and industrial labs to explore large-scale genome projects with fewer resources. These advances are not only expanding the accessibility of genome synthesis to a wider range of researchers but are also accelerating the commercial viability of synthetic organisms for practical use in sectors like energy, agriculture, and health.

What Key Applications Are Driving Demand for Whole Genome Synthesis Across Industries?

The practical applications of whole genome synthesis are expanding rapidly across a variety of sectors, each leveraging synthetic genomes to solve complex challenges and introduce new capabilities. In the pharmaceutical industry, custom genomes are being used to produce rare natural compounds, biosimilars, and next-generation antibiotics by engineering microbes to act as microfactories. The agricultural sector is exploring synthetic genomes to develop pest-resistant, drought-tolerant, and high-yield crop strains, offering solutions to food security in the face of climate change and growing global populations. In the field of bioenergy, synthetic microorganisms are being tailored to efficiently convert biomass into renewable fuels and chemicals, reducing dependence on fossil resources. Environmental applications include the development of organisms that can degrade pollutants, recycle waste, or sequester carbon dioxide, contributing to sustainability goals. Additionally, synthetic genomes are playing a critical role in vaccine development, where precise control over viral vectors and adjuvants enhances efficacy and safety. Academic institutions and research labs are also utilizing synthetic genomes to create minimal cells that provide insights into the fundamental requirements for life and biological self-organization. Even the space exploration industry is investigating synthetic biology for potential use in life-support systems and resource generation in extraterrestrial environments. The broad utility and transformative potential of genome synthesis are making it a central tool in both scientific exploration and real-world problem-solving across disciplines.

What Market Forces and Strategic Trends Are Fueling the Global Expansion of Genome Synthesis?

The global market for whole genome synthesis is being fueled by a combination of scientific ambition, industrial demand, and strategic investment that together are transforming the scale and scope of genetic engineering. The falling cost of DNA synthesis, along with advancements in assembly and verification technologies, is lowering barriers to entry and enabling more organizations to engage in synthetic genome projects. Government funding programs aimed at biotechnology innovation are supporting academic and industrial efforts to push the boundaries of synthetic biology, while private investment from venture capital and biotech firms is accelerating commercialization. Regulatory frameworks are gradually evolving to accommodate synthetic biology, providing clearer guidelines and fostering public trust through transparency and safety assessments. Increased collaboration between academia, startups, and established life sciences companies is fostering a robust innovation ecosystem where genome synthesis capabilities are refined and applied to diverse use cases. The emergence of biofoundries and dedicated synthesis labs is creating centralized hubs that support high-throughput, cost-effective genome engineering on a global scale. Intellectual property strategies are also shaping market dynamics, as organizations seek to patent novel organisms, methods, and sequences that have commercial value. At the same time, ethical discussions around the creation of synthetic life are prompting important conversations that influence research agendas and societal adoption. These converging forces are building a dynamic, forward-looking market where whole genome synthesis stands as a transformative driver of next-generation biotechnological solutions.

SCOPE OF STUDY:

The report analyzes the Whole Genome Synthesis market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Software & Service Component, Consumables Component, Instrument Component); Application (Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application, Other Applications); End-User (Pharma & Biotech Companies End-User, Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

• Ansa Biotechnologies
• ATUM
• Azenta (GENEWIZ)
• Bio Basic Inc.
• Bioneer Pacific Co. Ltd.
• Blue Heron Biotech (OriGene)
• Brooks Automation
• Elegen Corporation
• Eurofins Genomics
• Genewiz (Azenta)
• GenScript Biotech Corporation
• Icon Genetics
• Integrated DNA Technologies
• J. Craig Venter Institute
• Merck KGaA
• ProteoGenix Inc.
• Synbio Technologies
• Synbio Technologies
• Thermo Fisher Scientific
• Twist Bioscience

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Whole Genome Synthesis - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Synthetic Biology Advancements Throw the Spotlight on Demand for De Novo Genome Construction
  • Rise of DNA Foundries and Biofoundries Spurs Growth in Automated Whole Genome Synthesis Platforms
  • Expanding Applications in Vaccine and Therapeutic Development Strengthen the Business Case for Genome Synthesis
  • Biomanufacturing and Industrial Biotech Innovation Expands Addressable Market for Synthetic Genomes
  • Accelerated Drug Discovery Workflows Drive Adoption of Genome Synthesis in Cell Line Engineering
  • National Biosecurity and Bioeconomy Strategies Create Tailwinds for Domestic Genome Synthesis Capabilities
  • CRISPR and Gene Editing Integration Enhances the Value Proposition of Whole Genome Synthesis
  • Demand for Pathogen Genome Reconstruction in Infectious Disease Research Fuels Market Momentum
  • AI and Machine Learning Applications in Genome Design Drive Innovation in Predictive Synthesis Pipelines
  • Data-Driven Design Tools and CAD Software Adoption Propel Standardization of Genome Engineering
  • Ethical, Legal, and Regulatory Frameworks Influence Commercialization of Synthetic Genomes
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Whole Genome Synthesis Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Whole Genome Synthesis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Whole Genome Synthesis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Whole Genome Synthesis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Software & Service Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Software & Service Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Software & Service Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Consumables Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Consumables Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Consumables Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Instrument Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Instrument Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Instrument Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Diagnostic Laboratories End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Diagnostic Laboratories End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Diagnostic Laboratories End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Academic & Research Institutes End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Academic & Research Institutes End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Academic & Research Institutes End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Contract Research Organizations End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Contract Research Organizations End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Contract Research Organizations End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Pharma & Biotech Companies End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Pharma & Biotech Companies End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Personalized Medicine Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Personalized Medicine Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for Personalized Medicine Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Agricultural Biotechnology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Agricultural Biotechnology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 31: World 16-Year Perspective for Agricultural Biotechnology Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Synthetic Biology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Synthetic Biology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 34: World 16-Year Perspective for Synthetic Biology Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Industrial Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Industrial Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 37: World 16-Year Perspective for Industrial Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 40: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Whole Genome Synthesis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 41: USA Recent Past, Current & Future Analysis for Whole Genome Synthesis by Component - Software & Service Component, Consumables Component and Instrument Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Whole Genome Synthesis by Component - Software & Service Component, Consumables Component and Instrument Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 43: USA 16-Year Perspective for Whole Genome Synthesis by Component - Percentage Breakdown of Value Sales for Software & Service Component, Consumables Component and Instrument Component for the Years 2014, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for Whole Genome Synthesis by End-user - Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Whole Genome Synthesis by End-user - Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 46: USA 16-Year Perspective for Whole Genome Synthesis by End-user - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User for the Years 2014, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for Whole Genome Synthesis by Application - Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Whole Genome Synthesis by Application - Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 49: USA 16-Year Perspective for Whole Genome Synthesis by Application - Percentage Breakdown of Value Sales for Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Whole Genome Synthesis by Component - Software & Service Component, Consumables Component and Instrument Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Whole Genome Synthesis by Component - Software & Service Component, Consumables Component and Instrument Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 52: Canada 16-Year Perspective for Whole Genome Synthesis by Component - Percentage Breakdown of Value Sales for Software & Service Component, Consumables Component and Instrument Component for the Years 2014, 2025 & 2030
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Whole Genome Synthesis by End-user - Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Whole Genome Synthesis by End-user - Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 55: Canada 16-Year Perspective for Whole Genome Synthesis by End-user - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User for the Years 2014, 2025 & 2030
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Whole Genome Synthesis by Application - Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Whole Genome Synthesis by Application - Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 58: Canada 16-Year Perspective for Whole Genome Synthesis by Application - Percentage Breakdown of Value Sales for Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications for the Years 2014, 2025 & 2030
• JAPAN
  • Whole Genome Synthesis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Whole Genome Synthesis by Component - Software & Service Component, Consumables Component and Instrument Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Whole Genome Synthesis by Component - Software & Service Component, Consumables Component and Instrument Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 61: Japan 16-Year Perspective for Whole Genome Synthesis by Component - Percentage Breakdown of Value Sales for Software & Service Component, Consumables Component and Instrument Component for the Years 2014, 2025 & 2030
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Whole Genome Synthesis by End-user - Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Whole Genome Synthesis by End-user - Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 64: Japan 16-Year Perspective for Whole Genome Synthesis by End-user - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User for the Years 2014, 2025 & 2030
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Whole Genome Synthesis by Application - Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Whole Genome Synthesis by Application - Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 67: Japan 16-Year Perspective for Whole Genome Synthesis by Application - Percentage Breakdown of Value Sales for Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications for the Years 2014, 2025 & 2030
• CHINA
  • Whole Genome Synthesis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 68: China Recent Past, Current & Future Analysis for Whole Genome Synthesis by Component - Software & Service Component, Consumables Component and Instrument Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: China Historic Review for Whole Genome Synthesis by Component - Software & Service Component, Consumables Component and Instrument Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 70: China 16-Year Perspective for Whole Genome Synthesis by Component - Percentage Breakdown of Value Sales for Software & Service Component, Consumables Component and Instrument Component for the Years 2014, 2025 & 2030
  • TABLE 71: China Recent Past, Current & Future Analysis for Whole Genome Synthesis by End-user - Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: China Historic Review for Whole Genome Synthesis by End-user - Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 73: China 16-Year Perspective for Whole Genome Synthesis by End-user - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User for the Years 2014, 2025 & 2030
  • TABLE 74: China Recent Past, Current & Future Analysis for Whole Genome Synthesis by Application - Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Whole Genome Synthesis by Application - Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 76: China 16-Year Perspective for Whole Genome Synthesis by Application - Percentage Breakdown of Value Sales for Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications for the Years 2014, 2025 & 2030
• EUROPE
  • Whole Genome Synthesis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Whole Genome Synthesis by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Whole Genome Synthesis by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 79: Europe 16-Year Perspective for Whole Genome Synthesis by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Whole Genome Synthesis by Component - Software & Service Component, Consumables Component and Instrument Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Whole Genome Synthesis by Component - Software & Service Component, Consumables Component and Instrument Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 82: Europe 16-Year Perspective for Whole Genome Synthesis by Component - Percentage Breakdown of Value Sales for Software & Service Component, Consumables Component and Instrument Component for the Years 2014, 2025 & 2030
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Whole Genome Synthesis by End-user - Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Whole Genome Synthesis by End-user - Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 85: Europe 16-Year Perspective for Whole Genome Synthesis by End-user - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User for the Years 2014, 2025 & 2030
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Whole Genome Synthesis by Application - Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Whole Genome Synthesis by Application - Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 88: Europe 16-Year Perspective for Whole Genome Synthesis by Application - Percentage Breakdown of Value Sales for Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications for the Years 2014, 2025 & 2030
• FRANCE
  • Whole Genome Synthesis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 89: France Recent Past, Current & Future Analysis for Whole Genome Synthesis by Component - Software & Service Component, Consumables Component and Instrument Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: France Historic Review for Whole Genome Synthesis by Component - Software & Service Component, Consumables Component and Instrument Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 91: France 16-Year Perspective for Whole Genome Synthesis by Component - Percentage Breakdown of Value Sales for Software & Service Component, Consumables Component and Instrument Component for the Years 2014, 2025 & 2030
  • TABLE 92: France Recent Past, Current & Future Analysis for Whole Genome Synthesis by End-user - Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: France Historic Review for Whole Genome Synthesis by End-user - Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 94: France 16-Year Perspective for Whole Genome Synthesis by End-user - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User for the Years 2014, 2025 & 2030
  • TABLE 95: France Recent Past, Current & Future Analysis for Whole Genome Synthesis by Application - Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: France Historic Review for Whole Genome Synthesis by Application - Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 97: France 16-Year Perspective for Whole Genome Synthesis by Application - Percentage Breakdown of Value Sales for Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications for the Years 2014, 2025 & 2030
• GERMANY
  • Whole Genome Synthesis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 98: Germany Recent Past, Current & Future Analysis for Whole Genome Synthesis by Component - Software & Service Component, Consumables Component and Instrument Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for Whole Genome Synthesis by Component - Software & Service Component, Consumables Component and Instrument Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 100: Germany 16-Year Perspective for Whole Genome Synthesis by Component - Percentage Breakdown of Value Sales for Software & Service Component, Consumables Component and Instrument Component for the Years 2014, 2025 & 2030
  • TABLE 101: Germany Recent Past, Current & Future Analysis for Whole Genome Synthesis by End-user - Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Germany Historic Review for Whole Genome Synthesis by End-user - Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 103: Germany 16-Year Perspective for Whole Genome Synthesis by End-user - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User for the Years 2014, 2025 & 2030
  • TABLE 104: Germany Recent Past, Current & Future Analysis for Whole Genome Synthesis by Application - Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Germany Historic Review for Whole Genome Synthesis by Application - Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 106: Germany 16-Year Perspective for Whole Genome Synthesis by Application - Percentage Breakdown of Value Sales for Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 107: Italy Recent Past, Current & Future Analysis for Whole Genome Synthesis by Component - Software & Service Component, Consumables Component and Instrument Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for Whole Genome Synthesis by Component - Software & Service Component, Consumables Component and Instrument Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 109: Italy 16-Year Perspective for Whole Genome Synthesis by Component - Percentage Breakdown of Value Sales for Software & Service Component, Consumables Component and Instrument Component for the Years 2014, 2025 & 2030
  • TABLE 110: Italy Recent Past, Current & Future Analysis for Whole Genome Synthesis by End-user - Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Italy Historic Review for Whole Genome Synthesis by End-user - Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 112: Italy 16-Year Perspective for Whole Genome Synthesis by End-user - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User for the Years 2014, 2025 & 2030
  • TABLE 113: Italy Recent Past, Current & Future Analysis for Whole Genome Synthesis by Application - Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Italy Historic Review for Whole Genome Synthesis by Application - Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 115: Italy 16-Year Perspective for Whole Genome Synthesis by Application - Percentage Breakdown of Value Sales for Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Whole Genome Synthesis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 116: UK Recent Past, Current & Future Analysis for Whole Genome Synthesis by Component - Software & Service Component, Consumables Component and Instrument Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for Whole Genome Synthesis by Component - Software & Service Component, Consumables Component and Instrument Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 118: UK 16-Year Perspective for Whole Genome Synthesis by Component - Percentage Breakdown of Value Sales for Software & Service Component, Consumables Component and Instrument Component for the Years 2014, 2025 & 2030
  • TABLE 119: UK Recent Past, Current & Future Analysis for Whole Genome Synthesis by End-user - Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: UK Historic Review for Whole Genome Synthesis by End-user - Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 121: UK 16-Year Perspective for Whole Genome Synthesis by End-user - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User for the Years 2014, 2025 & 2030
  • TABLE 122: UK Recent Past, Current & Future Analysis for Whole Genome Synthesis by Application - Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: UK Historic Review for Whole Genome Synthesis by Application - Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 124: UK 16-Year Perspective for Whole Genome Synthesis by Application - Percentage Breakdown of Value Sales for Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 125: Spain Recent Past, Current & Future Analysis for Whole Genome Synthesis by Component - Software & Service Component, Consumables Component and Instrument Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for Whole Genome Synthesis by Component - Software & Service Component, Consumables Component and Instrument Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 127: Spain 16-Year Perspective for Whole Genome Synthesis by Component - Percentage Breakdown of Value Sales for Software & Service Component, Consumables Component and Instrument Component for the Years 2014, 2025 & 2030
  • TABLE 128: Spain Recent Past, Current & Future Analysis for Whole Genome Synthesis by End-user - Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Spain Historic Review for Whole Genome Synthesis by End-user - Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 130: Spain 16-Year Perspective for Whole Genome Synthesis by End-user - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User for the Years 2014, 2025 & 2030
  • TABLE 131: Spain Recent Past, Current & Future Analysis for Whole Genome Synthesis by Application - Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Spain Historic Review for Whole Genome Synthesis by Application - Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 133: Spain 16-Year Perspective for Whole Genome Synthesis by Application - Percentage Breakdown of Value Sales for Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 134: Russia Recent Past, Current & Future Analysis for Whole Genome Synthesis by Component - Software & Service Component, Consumables Component and Instrument Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for Whole Genome Synthesis by Component - Software & Service Component, Consumables Component and Instrument Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 136: Russia 16-Year Perspective for Whole Genome Synthesis by Component - Percentage Breakdown of Value Sales for Software & Service Component, Consumables Component and Instrument Component for the Years 2014, 2025 & 2030
  • TABLE 137: Russia Recent Past, Current & Future Analysis for Whole Genome Synthesis by End-user - Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Russia Historic Review for Whole Genome Synthesis by End-user - Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 139: Russia 16-Year Perspective for Whole Genome Synthesis by End-user - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User for the Years 2014, 2025 & 2030
  • TABLE 140: Russia Recent Past, Current & Future Analysis for Whole Genome Synthesis by Application - Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Russia Historic Review for Whole Genome Synthesis by Application - Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 142: Russia 16-Year Perspective for Whole Genome Synthesis by Application - Percentage Breakdown of Value Sales for Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Whole Genome Synthesis by Component - Software & Service Component, Consumables Component and Instrument Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for Whole Genome Synthesis by Component - Software & Service Component, Consumables Component and Instrument Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 145: Rest of Europe 16-Year Perspective for Whole Genome Synthesis by Component - Percentage Breakdown of Value Sales for Software & Service Component, Consumables Component and Instrument Component for the Years 2014, 2025 & 2030
  • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Whole Genome Synthesis by End-user - Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Rest of Europe Historic Review for Whole Genome Synthesis by End-user - Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 148: Rest of Europe 16-Year Perspective for Whole Genome Synthesis by End-user - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User for the Years 2014, 2025 & 2030
  • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Whole Genome Synthesis by Application - Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Rest of Europe Historic Review for Whole Genome Synthesis by Application - Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 151: Rest of Europe 16-Year Perspective for Whole Genome Synthesis by Application - Percentage Breakdown of Value Sales for Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Whole Genome Synthesis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Whole Genome Synthesis by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Whole Genome Synthesis by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 16-Year Perspective for Whole Genome Synthesis by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Whole Genome Synthesis by Component - Software & Service Component, Consumables Component and Instrument Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Whole Genome Synthesis by Component - Software & Service Component, Consumables Component and Instrument Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 16-Year Perspective for Whole Genome Synthesis by Component - Percentage Breakdown of Value Sales for Software & Service Component, Consumables Component and Instrument Component for the Years 2014, 2025 & 2030
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Whole Genome Synthesis by End-user - Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Whole Genome Synthesis by End-user - Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 16-Year Perspective for Whole Genome Synthesis by End-user - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User for the Years 2014, 2025 & 2030
  • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Whole Genome Synthesis by Application - Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Asia-Pacific Historic Review for Whole Genome Synthesis by Application - Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 163: Asia-Pacific 16-Year Perspective for Whole Genome Synthesis by Application - Percentage Breakdown of Value Sales for Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Whole Genome Synthesis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 164: Australia Recent Past, Current & Future Analysis for Whole Genome Synthesis by Component - Software & Service Component, Consumables Component and Instrument Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for Whole Genome Synthesis by Component - Software & Service Component, Consumables Component and Instrument Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 166: Australia 16-Year Perspective for Whole Genome Synthesis by Component - Percentage Breakdown of Value Sales for Software & Service Component, Consumables Component and Instrument Component for the Years 2014, 2025 & 2030
  • TABLE 167: Australia Recent Past, Current & Future Analysis for Whole Genome Synthesis by End-user - Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Australia Historic Review for Whole Genome Synthesis by End-user - Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 169: Australia 16-Year Perspective for Whole Genome Synthesis by End-user - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User for the Years 2014, 2025 & 2030
  • TABLE 170: Australia Recent Past, Current & Future Analysis for Whole Genome Synthesis by Application - Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Australia Historic Review for Whole Genome Synthesis by Application - Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 172: Australia 16-Year Perspective for Whole Genome Synthesis by Application - Percentage Breakdown of Value Sales for Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications for the Years 2014, 2025 & 2030
• INDIA
  • Whole Genome Synthesis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 173: India Recent Past, Current & Future Analysis for Whole Genome Synthesis by Component - Software & Service Component, Consumables Component and Instrument Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: India Historic Review for Whole Genome Synthesis by Component - Software & Service Component, Consumables Component and Instrument Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 175: India 16-Year Perspective for Whole Genome Synthesis by Component - Percentage Breakdown of Value Sales for Software & Service Component, Consumables Component and Instrument Component for the Years 2014, 2025 & 2030
  • TABLE 176: India Recent Past, Current & Future Analysis for Whole Genome Synthesis by End-user - Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: India Historic Review for Whole Genome Synthesis by End-user - Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 178: India 16-Year Perspective for Whole Genome Synthesis by End-user - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User for the Years 2014, 2025 & 2030
  • TABLE 179: India Recent Past, Current & Future Analysis for Whole Genome Synthesis by Application - Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: India Historic Review for Whole Genome Synthesis by Application - Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 181: India 16-Year Perspective for Whole Genome Synthesis by Application - Percentage Breakdown of Value Sales for Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for Whole Genome Synthesis by Component - Software & Service Component, Consumables Component and Instrument Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for Whole Genome Synthesis by Component - Software & Service Component, Consumables Component and Instrument Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 184: South Korea 16-Year Perspective for Whole Genome Synthesis by Component - Percentage Breakdown of Value Sales for Software & Service Component, Consumables Component and Instrument Component for the Years 2014, 2025 & 2030
  • TABLE 185: South Korea Recent Past, Current & Future Analysis for Whole Genome Synthesis by End-user - Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: South Korea Historic Review for Whole Genome Synthesis by End-user - Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 187: South Korea 16-Year Perspective for Whole Genome Synthesis by End-user - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User for the Years 2014, 2025 & 2030
  • TABLE 188: South Korea Recent Past, Current & Future Analysis for Whole Genome Synthesis by Application - Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: South Korea Historic Review for Whole Genome Synthesis by Application - Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 190: South Korea 16-Year Perspective for Whole Genome Synthesis by Application - Percentage Breakdown of Value Sales for Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Whole Genome Synthesis by Component - Software & Service Component, Consumables Component and Instrument Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for Whole Genome Synthesis by Component - Software & Service Component, Consumables Component and Instrument Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 16-Year Perspective for Whole Genome Synthesis by Component - Percentage Breakdown of Value Sales for Software & Service Component, Consumables Component and Instrument Component for the Years 2014, 2025 & 2030
  • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Whole Genome Synthesis by End-user - Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Asia-Pacific Historic Review for Whole Genome Synthesis by End-user - Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 196: Rest of Asia-Pacific 16-Year Perspective for Whole Genome Synthesis by End-user - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User for the Years 2014, 2025 & 2030
  • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Whole Genome Synthesis by Application - Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Asia-Pacific Historic Review for Whole Genome Synthesis by Application - Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 199: Rest of Asia-Pacific 16-Year Perspective for Whole Genome Synthesis by Application - Percentage Breakdown of Value Sales for Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Whole Genome Synthesis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Whole Genome Synthesis by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Whole Genome Synthesis by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 202: Latin America 16-Year Perspective for Whole Genome Synthesis by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Whole Genome Synthesis by Component - Software & Service Component, Consumables Component and Instrument Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Whole Genome Synthesis by Component - Software & Service Component, Consumables Component and Instrument Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 205: Latin America 16-Year Perspective for Whole Genome Synthesis by Component - Percentage Breakdown of Value Sales for Software & Service Component, Consumables Component and Instrument Component for the Years 2014, 2025 & 2030
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Whole Genome Synthesis by End-user - Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Whole Genome Synthesis by End-user - Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 208: Latin America 16-Year Perspective for Whole Genome Synthesis by End-user - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User for the Years 2014, 2025 & 2030
  • TABLE 209: Latin America Recent Past, Current & Future Analysis for Whole Genome Synthesis by Application - Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Latin America Historic Review for Whole Genome Synthesis by Application - Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 211: Latin America 16-Year Perspective for Whole Genome Synthesis by Application - Percentage Breakdown of Value Sales for Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for Whole Genome Synthesis by Component - Software & Service Component, Consumables Component and Instrument Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for Whole Genome Synthesis by Component - Software & Service Component, Consumables Component and Instrument Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 214: Argentina 16-Year Perspective for Whole Genome Synthesis by Component - Percentage Breakdown of Value Sales for Software & Service Component, Consumables Component and Instrument Component for the Years 2014, 2025 & 2030
  • TABLE 215: Argentina Recent Past, Current & Future Analysis for Whole Genome Synthesis by End-user - Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Argentina Historic Review for Whole Genome Synthesis by End-user - Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 217: Argentina 16-Year Perspective for Whole Genome Synthesis by End-user - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User for the Years 2014, 2025 & 2030
  • TABLE 218: Argentina Recent Past, Current & Future Analysis for Whole Genome Synthesis by Application - Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Argentina Historic Review for Whole Genome Synthesis by Application - Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 220: Argentina 16-Year Perspective for Whole Genome Synthesis by Application - Percentage Breakdown of Value Sales for Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for Whole Genome Synthesis by Component - Software & Service Component, Consumables Component and Instrument Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for Whole Genome Synthesis by Component - Software & Service Component, Consumables Component and Instrument Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 223: Brazil 16-Year Perspective for Whole Genome Synthesis by Component - Percentage Breakdown of Value Sales for Software & Service Component, Consumables Component and Instrument Component for the Years 2014, 2025 & 2030
  • TABLE 224: Brazil Recent Past, Current & Future Analysis for Whole Genome Synthesis by End-user - Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Brazil Historic Review for Whole Genome Synthesis by End-user - Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 226: Brazil 16-Year Perspective for Whole Genome Synthesis by End-user - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User for the Years 2014, 2025 & 2030
  • TABLE 227: Brazil Recent Past, Current & Future Analysis for Whole Genome Synthesis by Application - Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Brazil Historic Review for Whole Genome Synthesis by Application - Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 229: Brazil 16-Year Perspective for Whole Genome Synthesis by Application - Percentage Breakdown of Value Sales for Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for Whole Genome Synthesis by Component - Software & Service Component, Consumables Component and Instrument Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for Whole Genome Synthesis by Component - Software & Service Component, Consumables Component and Instrument Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 232: Mexico 16-Year Perspective for Whole Genome Synthesis by Component - Percentage Breakdown of Value Sales for Software & Service Component, Consumables Component and Instrument Component for the Years 2014, 2025 & 2030
  • TABLE 233: Mexico Recent Past, Current & Future Analysis for Whole Genome Synthesis by End-user - Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Mexico Historic Review for Whole Genome Synthesis by End-user - Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 235: Mexico 16-Year Perspective for Whole Genome Synthesis by End-user - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User for the Years 2014, 2025 & 2030
  • TABLE 236: Mexico Recent Past, Current & Future Analysis for Whole Genome Synthesis by Application - Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Mexico Historic Review for Whole Genome Synthesis by Application - Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 238: Mexico 16-Year Perspective for Whole Genome Synthesis by Application - Percentage Breakdown of Value Sales for Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Whole Genome Synthesis by Component - Software & Service Component, Consumables Component and Instrument Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for Whole Genome Synthesis by Component - Software & Service Component, Consumables Component and Instrument Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 241: Rest of Latin America 16-Year Perspective for Whole Genome Synthesis by Component - Percentage Breakdown of Value Sales for Software & Service Component, Consumables Component and Instrument Component for the Years 2014, 2025 & 2030
  • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Whole Genome Synthesis by End-user - Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Latin America Historic Review for Whole Genome Synthesis by End-user - Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 244: Rest of Latin America 16-Year Perspective for Whole Genome Synthesis by End-user - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User for the Years 2014, 2025 & 2030
  • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Whole Genome Synthesis by Application - Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Latin America Historic Review for Whole Genome Synthesis by Application - Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 247: Rest of Latin America 16-Year Perspective for Whole Genome Synthesis by Application - Percentage Breakdown of Value Sales for Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Whole Genome Synthesis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Whole Genome Synthesis by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Whole Genome Synthesis by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 250: Middle East 16-Year Perspective for Whole Genome Synthesis by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Whole Genome Synthesis by Component - Software & Service Component, Consumables Component and Instrument Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Whole Genome Synthesis by Component - Software & Service Component, Consumables Component and Instrument Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 253: Middle East 16-Year Perspective for Whole Genome Synthesis by Component - Percentage Breakdown of Value Sales for Software & Service Component, Consumables Component and Instrument Component for the Years 2014, 2025 & 2030
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Whole Genome Synthesis by End-user - Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Whole Genome Synthesis by End-user - Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 256: Middle East 16-Year Perspective for Whole Genome Synthesis by End-user - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User for the Years 2014, 2025 & 2030
  • TABLE 257: Middle East Recent Past, Current & Future Analysis for Whole Genome Synthesis by Application - Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Middle East Historic Review for Whole Genome Synthesis by Application - Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 259: Middle East 16-Year Perspective for Whole Genome Synthesis by Application - Percentage Breakdown of Value Sales for Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 260: Iran Recent Past, Current & Future Analysis for Whole Genome Synthesis by Component - Software & Service Component, Consumables Component and Instrument Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for Whole Genome Synthesis by Component - Software & Service Component, Consumables Component and Instrument Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 262: Iran 16-Year Perspective for Whole Genome Synthesis by Component - Percentage Breakdown of Value Sales for Software & Service Component, Consumables Component and Instrument Component for the Years 2014, 2025 & 2030
  • TABLE 263: Iran Recent Past, Current & Future Analysis for Whole Genome Synthesis by End-user - Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Iran Historic Review for Whole Genome Synthesis by End-user - Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 265: Iran 16-Year Perspective for Whole Genome Synthesis by End-user - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User for the Years 2014, 2025 & 2030
  • TABLE 266: Iran Recent Past, Current & Future Analysis for Whole Genome Synthesis by Application - Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Iran Historic Review for Whole Genome Synthesis by Application - Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 268: Iran 16-Year Perspective for Whole Genome Synthesis by Application - Percentage Breakdown of Value Sales for Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 269: Israel Recent Past, Current & Future Analysis for Whole Genome Synthesis by Component - Software & Service Component, Consumables Component and Instrument Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for Whole Genome Synthesis by Component - Software & Service Component, Consumables Component and Instrument Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 271: Israel 16-Year Perspective for Whole Genome Synthesis by Component - Percentage Breakdown of Value Sales for Software & Service Component, Consumables Component and Instrument Component for the Years 2014, 2025 & 2030
  • TABLE 272: Israel Recent Past, Current & Future Analysis for Whole Genome Synthesis by End-user - Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Israel Historic Review for Whole Genome Synthesis by End-user - Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 274: Israel 16-Year Perspective for Whole Genome Synthesis by End-user - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User for the Years 2014, 2025 & 2030
  • TABLE 275: Israel Recent Past, Current & Future Analysis for Whole Genome Synthesis by Application - Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Israel Historic Review for Whole Genome Synthesis by Application - Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 277: Israel 16-Year Perspective for Whole Genome Synthesis by Application - Percentage Breakdown of Value Sales for Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Whole Genome Synthesis by Component - Software & Service Component, Consumables Component and Instrument Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for Whole Genome Synthesis by Component - Software & Service Component, Consumables Component and Instrument Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 280: Saudi Arabia 16-Year Perspective for Whole Genome Synthesis by Component - Percentage Breakdown of Value Sales for Software & Service Component, Consumables Component and Instrument Component for the Years 2014, 2025 & 2030
  • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Whole Genome Synthesis by End-user - Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Saudi Arabia Historic Review for Whole Genome Synthesis by End-user - Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 283: Saudi Arabia 16-Year Perspective for Whole Genome Synthesis by End-user - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User for the Years 2014, 2025 & 2030
  • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Whole Genome Synthesis by Application - Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Saudi Arabia Historic Review for Whole Genome Synthesis by Application - Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 286: Saudi Arabia 16-Year Perspective for Whole Genome Synthesis by Application - Percentage Breakdown of Value Sales for Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 287: UAE Recent Past, Current & Future Analysis for Whole Genome Synthesis by Component - Software & Service Component, Consumables Component and Instrument Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for Whole Genome Synthesis by Component - Software & Service Component, Consumables Component and Instrument Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 289: UAE 16-Year Perspective for Whole Genome Synthesis by Component - Percentage Breakdown of Value Sales for Software & Service Component, Consumables Component and Instrument Component for the Years 2014, 2025 & 2030
  • TABLE 290: UAE Recent Past, Current & Future Analysis for Whole Genome Synthesis by End-user - Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: UAE Historic Review for Whole Genome Synthesis by End-user - Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 292: UAE 16-Year Perspective for Whole Genome Synthesis by End-user - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User for the Years 2014, 2025 & 2030
  • TABLE 293: UAE Recent Past, Current & Future Analysis for Whole Genome Synthesis by Application - Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: UAE Historic Review for Whole Genome Synthesis by Application - Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 295: UAE 16-Year Perspective for Whole Genome Synthesis by Application - Percentage Breakdown of Value Sales for Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Whole Genome Synthesis by Component - Software & Service Component, Consumables Component and Instrument Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for Whole Genome Synthesis by Component - Software & Service Component, Consumables Component and Instrument Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 298: Rest of Middle East 16-Year Perspective for Whole Genome Synthesis by Component - Percentage Breakdown of Value Sales for Software & Service Component, Consumables Component and Instrument Component for the Years 2014, 2025 & 2030
  • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Whole Genome Synthesis by End-user - Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Middle East Historic Review for Whole Genome Synthesis by End-user - Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 301: Rest of Middle East 16-Year Perspective for Whole Genome Synthesis by End-user - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User for the Years 2014, 2025 & 2030
  • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Whole Genome Synthesis by Application - Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Middle East Historic Review for Whole Genome Synthesis by Application - Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 304: Rest of Middle East 16-Year Perspective for Whole Genome Synthesis by Application - Percentage Breakdown of Value Sales for Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications for the Years 2014, 2025 & 2030
• AFRICA
  • Whole Genome Synthesis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 305: Africa Recent Past, Current & Future Analysis for Whole Genome Synthesis by Component - Software & Service Component, Consumables Component and Instrument Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for Whole Genome Synthesis by Component - Software & Service Component, Consumables Component and Instrument Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 307: Africa 16-Year Perspective for Whole Genome Synthesis by Component - Percentage Breakdown of Value Sales for Software & Service Component, Consumables Component and Instrument Component for the Years 2014, 2025 & 2030
  • TABLE 308: Africa Recent Past, Current & Future Analysis for Whole Genome Synthesis by End-user - Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Africa Historic Review for Whole Genome Synthesis by End-user - Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 310: Africa 16-Year Perspective for Whole Genome Synthesis by End-user - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User and Pharma & Biotech Companies End-User for the Years 2014, 2025 & 2030
  • TABLE 311: Africa Recent Past, Current & Future Analysis for Whole Genome Synthesis by Application - Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Africa Historic Review for Whole Genome Synthesis by Application - Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 313: Africa 16-Year Perspective for Whole Genome Synthesis by Application - Percentage Breakdown of Value Sales for Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application and Other Applications for the Years 2014, 2025 & 2030

IV. COMPETITION